Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Early recognition of methotrexate toxicity symptoms is crucial.

New test predicts if hair loss treatment will work.

Finasteride safely lowers DHT levels without affecting testosterone.

Testosterone increases seizure risk through its conversion to specific neurosteroids.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Tofacitinib, a hair regrowth treatment, may worsen acne.

New pyrazole derivatives may help treat hair loss, but more testing is needed.

Finasteride may help reduce COVID-19 infection by altering a key gene.

Molybdenum oxide nanozymes can effectively treat and monitor acute kidney injury by reducing oxidative stress.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Human platelets change minoxidil to minoxidil sulfate, helping blood vessels widen.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Finasteride worsens heart damage but reduces cell toxicity caused by nandrolone decanoate.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

Urtica laetevirens extract significantly reduces 5α-reductase activity.